首页> 外文期刊>Indian drugs >LIPID NANOPARTICLES FOR TRANSDERMAL DELIVERY OF CELECOXIB AN IN VITRO AND IN VIVO INVESTIGATION
【24h】

LIPID NANOPARTICLES FOR TRANSDERMAL DELIVERY OF CELECOXIB AN IN VITRO AND IN VIVO INVESTIGATION

机译:脂质纳米粒子用于塞克西布的透皮递送体外和体内调查

获取原文
获取原文并翻译 | 示例
       

摘要

In the present research work, celecoxib (CXB) loaded solid lipid nanoparticles (SLNs) were prepared using the probe sonication method, wherein Glyceryl monostearate and Tween 80 were used as solid lipid and surfactant, respectively. To obtain the statistically optimized batch, 3~2 factorial design was applied. The optimized batch was characterized physicochemically and evaluated through DSC, SEM and XRD studies. The mean particle size of the optimized batch was found to be 135.41 ± 0.24 nm with a mean % entrapment efficiency of 80 ± 1.69%. The optimized batch was further lyophilized and dispersed into 1% w/V Carbopol 934P to form a gel. Prepared gel was further evaluated for in vitro drug release, occlusivity, ex vivo permeability, local toxicity, in vivo anti-inflammatory activity and accelerated stability study. The study resulted in stable, safe and prolonged anti-inflammatory activity with quick onset of action. Hence, celecoxib loaded solid lipid nanoparticles can be considered as promising alternative to conventional topical systems.
机译:在本研究工作中,使用探针超声处理方法制备Celecoxib(CXB)装载的固体脂质纳米颗粒(SLNS),其中甘油单晶酸盐和吐温80分别用作固体脂质和表面活性剂。为了获得统计上优化的批次,应用了3〜2个因子设计。优化的批料在化学上进行了理解,并通过DSC,SEM和XRD研究评估。优化批料的平均粒度为135.41±0.24nm,其平均夹带效率为80±1.69%。优化的批次进一步冻干并分散到1%w / v carbopol 934p中以形成凝胶。进一步评价制备的凝胶,用于体外药物释放,闭塞性,离体渗透性,局部毒性,体内抗炎活性和加速稳定性研究。该研究导致稳定,安全和长期的抗炎活动,快速发作。因此,塞克西布负载的固体脂质纳米颗粒可以被认为是对常规局部系统的有前途的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号